Merger of drugmakers Valeant, Actavis on hold: source
(Reuters) - Talks are on hold to merge drugmakers Valeant Pharmaceuticals International Inc and Actavis Inc in a deal that would have created a healthcare giant, a person familiar with the situation told Reuters on Saturday.
A Valeant spokeswoman and an Actavis spokesman could not be immediately reached for comment outside of business hours.
(Reporting by Soyoung Kim in New York; writing by Rod Nickel in Winnipeg, Manitoba)
Time magazine named Pope Francis as its Person of the Year, crediting him with shifting the message of the Catholic Church. Slideshow
DETROIT/NEW YORK - Ford Motor Co's board of directors plans to press Chief Executive Alan Mulally soon for a decision on his future, as speculation intensifies that he may be offered the job of CEO at Microsoft Corp.
WASHINGTON - U.S. small business sentiment bounced back from a seven-month low in November, with owners setting their sights on creating more jobs and expanding operations.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.